Menopause statistics 2026: the numbers behind perimenopause, treatment and cost in the US

How many American women are in menopause right now?

The transition is not a niche event. It is a demographic wave that arrives on schedule every year, and it lasts far longer than the word "menopause" suggests.

• 1.3 million women enter menopause in the United States each year, roughly 6,000 a day (Menopause, StatPearls / NIH).
• Median age 51. Natural menopause most often occurs between 45 and 56 (StatPearls / NIH).
• Roughly a third of a woman's life is spent after menopause: US female life expectancy is about 81 years (CDC / NCHS), which leaves 30 or so postmenopausal years after a final period at 51.
• 7.4 years: the median duration of frequent hot flashes and night sweats across the transition, persisting a median 4.5 years after the final period (SWAN, JAMA Internal Medicine 2015).
• 59% of women aged 40 to 49 had never heard of perimenopause until they were in it, and 71% of all women say they felt unprepared for how disruptive symptoms would be (Bonafide, State of Menopause 2025, 2,000+ women aged 40 to 64).

How common are the symptoms, and how long do they last?

Hot flashes get the headlines, but sleep, weight, bone and genitourinary changes affect as many women and last longer. The complete perimenopause symptoms list walks through each one; these are the prevalence figures behind it.

• About 80% of women experience hot flashes or night sweats during the transition (SWAN). For Black women the median duration is longer: 10.1 years.
• 56% of perimenopausal women aged 40 to 59 sleep less than 7 hours a night, against 32.5% of premenopausal women; 30.8% have trouble staying asleep four or more nights a week (CDC / NCHS Data Brief 286, National Health Interview Survey 2015).
• Weight rises about 1.5 pounds a year in women aged 40 to 55, and the transition itself shifts body composition toward more fat and less lean mass (SWAN, JCI Insight 2019). Our guide on perimenopause weight gain explains why.
• 1 to 2% of bone density is lost per year in early menopause, sometimes 3 to 5%, and 1 in 2 women over 50 will break a bone because of osteoporosis (Endocrine Society; Bone Health & Osteoporosis Foundation).
• 27% to 84% of postmenopausal women have genitourinary syndrome of menopause (vaginal dryness, pain with sex, urinary symptoms), a condition the Menopause Society calls underdiagnosed and undertreated (NAMS 2020 position statement).
• 50% of women aged 40 to 49 say they don't feel like themselves, and they report hopelessness at 40% higher rates than women over 50 (Bonafide 2025).

How many women actually get treated?

This is the gap the numbers make hardest to ignore. Effective treatment exists, the guidelines support it, and most women never get it.

• 69% of symptomatic women aged 40 to 64 are not using any treatment (Bonafide, State of Menopause 2025).
• Hormone therapy use fell 82% in two decades: 26.9% of postmenopausal US women used it in 1999 to 2000, 4.7% in 2017 to 2020 (JAMA Health Forum 2024, NHANES, 13,048 women).
• 9.4% under age 52, 4.5% at 52 to 64: hormone therapy use by age in the same study. By race, 5.8% of non-Hispanic white women, 2.6% of Hispanic women and 0.5% of non-Hispanic Black women use it; private insurance roughly doubles the odds of use.
• Only 31.3% of US OB-GYN residency programs teach a menopause curriculum, while 92.9% of program directors say residents should have one (Menopause journal, 2023 survey of 99 program directors).
• 41% of women received conflicting advice from healthcare providers, and 24% of women aged 40 to 49 had a provider attribute their symptoms to anxiety (Bonafide 2025).
• Women aged 40 to 49 are three times as likely as older women to use a digital health platform for menopause care (Bonafide 2025). Our guide to finding a perimenopause doctor covers both routes.

What does menopause cost, at work and at the pharmacy?

Two kinds of cost show up in the data: what untreated symptoms cost the economy, and what treatment costs a woman paying out of pocket. The second set of figures is ours, checked against provider websites every month.

• $1.8 billion a year in lost work time, $26.6 billion including medical expenses: the estimated US cost of menopause symptoms, from a survey of 4,440 employed women aged 45 to 60 (Mayo Clinic Proceedings 202300112-X/abstract)). 13% reported an adverse work outcome and 11% missed work days because of symptoms.
• 45% of employed women with symptoms say they affected their work performance, 23% considered cutting their hours, and only 11% know of a formal menopause benefit at their employer (Carrot, Menopause in the Workplace 2025).
• $39 to $199 a month for hormone therapy medication through the seven telehealth providers we track, plus a one-time consult of $49 to $250 at most of them (our HRT cost breakdown, prices checked Sep 8, 2026).
• As little as $23 a month for generic estradiol and progesterone filled at a retail pharmacy with a discount card, the cheapest legitimate route (the cheapest ways to get HRT).
• $583.50 list price, about $773 at the pharmacy counter for Veozah, the non-hormonal hot flash drug, before its copay card (Veozah cost).

How to cite these statistics

Every figure above links to its primary source, with the study population and year stated so you can judge how far it travels. Survey figures (Bonafide, Carrot, KFF) describe the people surveyed, not all American women. Price figures are ours: we re-check each provider's published prices monthly and date every table. You are welcome to cite this page; a link back to it lets your readers see the sources and the date of the last update.